Search Results 1091-1100 of 17018 for hla genotype
Safety and efficacy study of SANGUINATE on reduction of delayed graft function (DGF) in patients who will be recipients of a donation after brain death (DBD) ...
The primary purpose of this dose escalation study is to estimate the maximum tolerated dose (MTD) and/or recommended dose for expansion (RDE) of LGH447 as a ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this double-blind study is to obtain the most unbiased assessment of clinical safety and efficacy with the doses of EDP-305 being studied.
Maximizing organ donors. Mayo Clinic researchers are developing innovative preservation methods that make more donated livers usable for transplant, helping to ...
Dr. Ertekin-Taner and her colleagues are exploring the role gene expression changes in the brain in Alzheimer's disease. The team is working to identify genes ...
Patients with Acute Myeloid Leukemia (AML) in complete remission will receive eltrombopag while undergoing consolidation chemotherapy with high-dose cytarabine.
Mayo Clinic researchers are committed to improving diagnosis and treatment of hemochromatosis. Their findings are helping improve care. Publications. See a list ...
The purpose of this study is to study both biopsy and surgical sample tissue to identify tumor-specific characteristics which may be associated with clinical ...
Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to determine the prevalence of genetic mutations in cancer patients from various ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!